Nenning P, Bourcevet H
Direktorat für Forschung, Karl-Marx-Universität Leipzig.
Pharmazie. 1990 Jul;45(7):525-7.
The possibility for GDR application for a patent of monoclonal antibodies are discussed in detail. Antibodies can be used advantageously as diagnostica. Basic suppositions for true patents in this field e.g. sufficient manifestation of the invention, newness and ingenious performance are referred. Possible algorithms for the formulation of the claims are given.
详细讨论了将基因诊断试剂（GDR）用于单克隆抗体专利申请的可能性。抗体可有利地用作诊断试剂。文中提及了该领域真正专利的基本假设，例如发明的充分体现、新颖性和创造性。还给出了权利要求书拟定的可能算法。
